Canadian university sets up international regulatory website:
This article was originally published in Clinica
Health law experts led by Professor Bartha Knoppers at the University of Montreal have established a website featuring international regulatory issues of interest to the healthcare industries - in particular for firms involved in genetics. Issues relating to medical devices and diagnostics and genetic testing are also featured, said team member Sylvain Poitras. Mr Poitras, visiting scholar with the team for 2003, was formerly legal counsel (responsible for regulatory affairs) at Medtronic Europe's headquarters in Lausanne, Switzerland. See www.humgen.umontreal.ca
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.